Boston Scientific Warns Cyberattack Will Hit 2026 Sales and Profit

Boston Scientific announced it is unlikely to meet its 2026 sales and profit forecasts due to a cyberattack that will materially impact third-quarter and full-year results, causing its stock to fall.

8 Sept, 10:27 — 8 Sept, 14:23

Post Share

Why this matters

Boston Scientific is a major medical devices company, and a cyberattack disrupting its operations can affect hospitals and patients relying on its products. The guidance miss signals broader cybersecurity risks in the healthcare sector.

Key entitiesBoston Scientific

The Story

What 7 sources agree on, dispute, and miss

What sources agree on

Boston Scientific announced it is unlikely to meet its 2026 sales and profit forecast due to a cyberattack.
The cyberattack has disrupted the company's ability to ship products to customers.
The announcement caused the stock to fall.

Key claims1 agreed · 3 unverified

✓

Boston Scientific is unlikely to meet its 2026 sales and profit forecast due to a cyberattack.

agreed·ReutersYahooBarron'swsjchannel-news-asia+2

The cyberattack has impacted Boston Scientific's ability to ship products to customers.

unverified·bloomberg

Boston Scientific's stock fell after the announcement.

unverified·Barron's

The cyberattack will materially hit Q3 results as well as full-year 2026 results.

unverified·seeking-alpha

Coverage gaps

Explicit mention of stock price decline following the announcement

ReportedBarron's

MissingReutersYahoowsj+3

Specific impact on ability to ship products

Reportedbloomberg

MissingReutersYahooBarron's+3

Material hit to Q3 results specifically, in addition to full-year

Reportedseeking-alpha

MissingReutersYahooBarron's+3

Coverage matrix

	Reuters	bloomberg	wsj	Barron's	Yahoo	channel-news-asia	seeking-alpha
Explicit mention of stock price decline following the announcement
Specific impact on ability to ship products
Material hit to Q3 results specifically, in addition to full-year

Covered Divergent Not mentioned

The Story

Analyzing sources…

Source Diversity

High (63/100)

7 sources33/33

Spectrum spread— 3/5 buckets covered17/33

Far L

Left1

Left (1)

Yahoo

Center2

Center (2)

bloombergReuters

Right4

Right (4)

Barron'swsjchannel-news-asiaseeking-alpha

Far R

Geographic diversity— 3 regions13/34

US5Intl1Singapore1

Political spectrum

LeftCenterRight

yahoo

reuters

bloomberg

barrons

channel-news-asia

seeking-alpha

wsj

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

Yahoocentercenter-leftneutralMostly Factualneutral wire copy

ReuterscentercenterneutralVery Highneutral wire service reporting

bloomberg

Coverage leans: center

Coverage is overwhelmingly factual and non-political, with outlets focusing on the business impact of the cyberattack. The known biases of some outlets (center-right) do not manifest in the reporting.

Sources

Showing 5 of 7 sources

ReutersVery High1d ago

Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack - Reuters

Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack Reuters

Read full article →

bloombergHigh22h ago

Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers

On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year. - Intel (INTC) is ris...

Read full article →

wsjHigh1d ago